Delta-opioid receptors attenuate TNF-α-induced MMP-2 secretion from human ONH astrocytes

Naseem Akhter1, Melissa Nix, Yasir Abdul

  • 1Hewitt Laboratory of the Ola B. Williams Glaucoma Center, Department of Ophthalmology, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina.

Abstract

Insights

The delta-opioid receptor agonist SNC-121 reduces tumor necrosis factor-alpha (TNF-α)-induced matrix metalloproteinase-2 (MMP-2) secretion in optic nerve head astrocytes. This effect involves the p38 MAP kinase and NF-κB signaling pathways.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Cell Biology

Background:

  • Tumor necrosis factor-alpha (TNF-α) can induce matrix metalloproteinase-2 (MMP-2) secretion.
  • MMP-2 plays a role in optic nerve head (ONH) remodeling and disease.
  • Understanding the regulation of MMP-2 secretion is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the signaling mechanisms by which the delta-opioid receptor agonist SNC-121 attenuates TNF-α-induced MMP-2 secretion from human ONH astrocytes.
  • To determine the involvement of p38 mitogen-activated protein (MAP) kinase and nuclear factor-kappa B (NF-κB) signaling pathways in this process.

Main Methods:

  • Human ONH astrocytes were treated with SNC-121 and/or TNF-α.
  • Inhibitors of p38 MAP kinase (SB-203580) and NF-κB (Helenalin) were used to block signaling pathways.
  • Western blotting was employed to measure protein phosphorylation and expression.
  • Immunocytochemistry was used to assess NF-κB translocation.

Main Results:

  • SNC-121 significantly reduced TNF-α-induced MMP-2 secretion from ONH astrocytes.
  • The inhibitory effect of SNC-121 was blocked by the delta-opioid receptor antagonist naltrindole.
  • TNF-α treatment increased p38 MAP kinase phosphorylation and NF-κB expression, which were attenuated by SNC-121.
  • Inhibitors of p38 MAP kinase and NF-κB blocked TNF-α-induced MMP-2 secretion.

Conclusions:

  • SNC-121 effectively attenuates TNF-α-induced MMP-2 secretion in human ONH astrocytes.
  • The p38 MAP kinase and NF-κB signaling pathways are critical mediators of TNF-α-induced MMP-2 secretion.
  • SNC-121 exerts its inhibitory effects through negative regulation of both p38 MAP kinase and NF-κB signaling.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...